187 related articles for article (PubMed ID: 18677209)
1. Usefulness of 99mTc-pertechnetate single-photon emission computed tomography in remnant mass estimation of postsurgical patients of differentiated thyroid cancer during internal dosimetry.
Nadig MR; Pant GS; Bal C
Nucl Med Commun; 2008 Sep; 29(9):809-14. PubMed ID: 18677209
[TBL] [Abstract][Full Text] [Related]
2. Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
Giovanella L; Suriano S; Ricci R; Ceriani L; Anton Verburg F
Head Neck; 2011 Apr; 33(4):552-6. PubMed ID: 20824809
[TBL] [Abstract][Full Text] [Related]
3. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
Chantadisai M; Kingpetch K
Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
[TBL] [Abstract][Full Text] [Related]
5. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation.
Thientunyakit T; Pusuwan P; Tuchinda P; Khiewvan B
J Med Assoc Thai; 2013 Sep; 96(9):1199-207. PubMed ID: 24163997
[TBL] [Abstract][Full Text] [Related]
6. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.
Ozdemir D; Cuhaci FN; Ozdemir E; Aydin C; Ersoy R; Turkolmez S; Cakir B
Nucl Med Commun; 2016 Jun; 37(6):640-5. PubMed ID: 26895488
[TBL] [Abstract][Full Text] [Related]
7. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma.
Long B; Li L; Yao L; Chen S; Yi H; Ye X; Xu D; Wu P
J Cancer Res Ther; 2015 Nov; 11 Suppl():C244-7. PubMed ID: 26612446
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
Lou K; Gu Y; Hu Y; Wang S; Shi H
Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the success of thyroid remnant ablation using preablative 99mTc pertechnetate scintigraphy and postablative dual 131I scintigraphy.
Jung JS; Lee SM; Kim SJ; Choi J; Han SW
Nucl Med Commun; 2015 Jan; 36(1):38-44. PubMed ID: 25299469
[TBL] [Abstract][Full Text] [Related]
10. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279. PubMed ID: 27782699
[TBL] [Abstract][Full Text] [Related]
11. Negative remnant
Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
[TBL] [Abstract][Full Text] [Related]
12.
Giovanella L; Paone G; Ruberto T; Ceriani L; Trimboli P
Endocrinol Metab (Seoul); 2019 Mar; 34(1):63-69. PubMed ID: 30784242
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery.
Samuel AM; Rajashekharrao B
J Nucl Med; 1994 Dec; 35(12):1944-50. PubMed ID: 7989975
[TBL] [Abstract][Full Text] [Related]
14. Estimation of thyroid mass in Graves' disease by a scintigraphic method.
Pant GS; Kumar R; Gupta AK; Sharma SK; Pandey AK
Nucl Med Commun; 2003 Jul; 24(7):743-8. PubMed ID: 12813191
[TBL] [Abstract][Full Text] [Related]
15. Distribution and dynamics of (99m)Tc-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living mice.
Franken PR; Guglielmi J; Vanhove C; Koulibaly M; Defrise M; Darcourt J; Pourcher T
Thyroid; 2010 May; 20(5):519-26. PubMed ID: 20384490
[TBL] [Abstract][Full Text] [Related]
16. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid carcinoma imaged by Tc-99m MIBI SPECT and Tl-201 chloride/Tc-99m pertechnetate subtraction SPECT.
Shih WJ; Stipp V; Magoun S; Ain KB; Pulmano C
Clin Nucl Med; 1996 Mar; 21(3):213-7. PubMed ID: 8846566
[TBL] [Abstract][Full Text] [Related]
18. Thyroid C-cell hyperplasia shown by combined In-111 pentetreotide, Tc-99m pertechnetate, and Tc-99m MIBI scintigraphy.
Cecchin D; Lumachi F; Marino F; Stramare R; Basso U; Grassetto G; Bui F
Clin Nucl Med; 2007 May; 32(5):378-9. PubMed ID: 17452867
[No Abstract] [Full Text] [Related]
19. Influence of (99m)Tc-pertechnetate thyroid imaging on radioactive iodine uptake.
Guo N; Yang K; Lin YS; Wang T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):267-70. PubMed ID: 24997818
[TBL] [Abstract][Full Text] [Related]
20. Role of Tc-99m pertechnetate for remnant scintigraphy post-thyroidectomy.
Kueh SS; Roach PJ; Schembri GP
Clin Nucl Med; 2010 Sep; 35(9):671-4. PubMed ID: 20706039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
